The ability to tissue engineer new hair follicles will help several patient populations, from people with androgenic alopecia to those who have suffered severe burns. In addition to cosmetic appearance, the hair follicle moisturizes the skin, provides protective sensation, and regulates body temperature. While the body can regenerate skin through normal wound healing and scarring, hair follicles are not replaced and burn patients suffer from dry, brittle skin and disfigurement. Interestingly, human fetal skin can regenerate new hair follicles, a capability which is lost after birth. Isolated human fetal hair follicle dermal stem cells (dermal papilla or DP cells) induce hair follicle regeneration in mouse models while adult DP cells do so with very low efficiency. Clearly, a change occurs in the DP cell population over time, corresponding to a loss of regenerative capacity. To identify the genes and pathways responsible for follicular regeneration, we compared the transcriptomes of fetal and adult DP cells.
PURPOSE:
The ability to tissue engineer new hair follicles will help several patient populations, from people with androgenic alopecia to those who have suffered severe burns. In addition to cosmetic appearance, the hair follicle moisturizes the skin, provides protective sensation, and regulates body temperature. While the body can regenerate skin through normal wound healing and scarring, hair follicles are not replaced and burn patients suffer from dry, brittle skin and disfigurement. Interestingly, human fetal skin can regenerate new hair follicles, a capability which is lost after birth. Isolated human fetal hair follicle dermal stem cells (dermal papilla or DP cells) induce hair follicle regeneration in mouse models while adult DP cells do so with very low efficiency. Clearly, a change occurs in the DP cell population over time, corresponding to a loss of regenerative capacity. To identify the genes and pathways responsible for follicular regeneration, we compared the transcriptomes of fetal and adult DP cells.
METHODS:
Dermal papilla cells from mature hair follicles in anagen phase were manually microdissected from frozen sections of 16-18 week human fetal scalp and 36-56 year old adult scalp. The dermal sheath (DS) and portions of interfollicular dermis (IFD) were used as controls. There is evidence to suggest that the dermal sheath also serves as a stem cell niche for the hair follicle. Total RNA extracted from the dissected cells was processed into RNA-seq libraries using Nugen's Ovation RNA-Seq System V2 and Ovation Ultralow Library System V2. 100 million total reads with a read length of 1x75 bp were sequenced for each sample using the Molecular Genomics Core at USC. Libraries were mapped to the human genome (hg19) using STAR and differential expression analysis was performed with EdgeR.
RESULTS:
A set of genes uniquely upregulated in the fetal DP as compared to adult DP, fetal IFD, and adult IFD populations was identified. The fetal DP and DS transcriptomes differed more significantly from the IFD population than did the adult DP and DS groups, suggesting that the DP and DS stem cell populations become more similar to interfollicular dermal fibroblasts with age. Shh, Wnt/bcatenin, and Notch signaling pathways were upregulated in fetal DP cells compared with adult DP cells. Notably, the Shh pathway was largely absent from the adult DP cell population. Many of the factors upregulated in fetal DP cells, such as Hey2, Sox2, Shh, and Msx1 are known to play a role in morphogenesis, stem cell pluripotency, and embryogenesis.
CONCLUSIONS:
Our data reveals many transcriptional differences between fetal DP cells, which can induce hair follicle regeneration, and adult DP cells, which cannot. Differential expression analysis demonstrated that multiple signaling pathways associated with stem cells and morphogenesis are upregulated in the fetal DP cells, suggesting that these same pathways may also confer the regenerative capacity. We have identified a set of candidate transcription factors to evaluate for use in transcriptional reprogramming of adult dermal fibroblasts into fetal-like DP cells with hair follicle-inducing capacity as a first step towards tissue engineering new hair follicles. PURPOSE: Service men and women commonly suffer extensive high-energy soft tissue damage to the face and limbs. Associated volumetric muscle loss can lead to devastating functional deficits. While existing therapies can help restore cosmesis, reconstructive options to restore function remain significantly limited. The use of decellularized extracellular matrix (ECM) has yielded promise in regenerative medicine, but no successful strategies yet exist that induce in situ regeneration of functional skeletal muscle. This study aimed to compare the myogenic capacity of commercially available acellular dermal matrices (ADM) to native dermal and muscular decellularized ECM.
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METHODS:
41 Sprague-Dawley rats underwent surgery to create bilateral 10 mm circular latissimus dorsi defects. Defects were assigned to defect alone, or implantation of AlloDerm®, Strattice™, decellularized rat muscle (DCM) or decellularized rat dermis (DCD). 30 and 60-day timepoints were analyzed. Decellularized native matrices were prepared from fresh tissues using a novel SDS protocol optimized to reduce encapsulation. Specimens were PSRC Abstract Supplement
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analyzed for gross appearance and stimulated prior to animal sacrifice to assess contraction. Histologic specimens were evaluated for integration and encapsulation. Immunofluorescence analysis was used to characterize neovascularisation and myogenesis. A comparative analysis of inflammation and fibrosis was performed by qPCR.
RESULTS: DCM showed markedly better gross incorporation than all other groups at 30 and 60 days, and were the only implants to contract upon direct electrical stimulation. Histologically, the commercially available ADM's demonstrated encapsulation at both 30 and 60 days, and Strattice™ showed peripheral hypercellularity and central acellularity, whereas native decellularized matrices showed integration. DCM CD-31 immunofluorescence revealed a developed microvascular network at 60 days, whereas AlloDerm®, DCD and defect demonstrated less neovasculature. Strattice™ showed no vascular ingrowth whatsoever. Native matrices showed evidence of MHC-positive myocytes within the peripheral regions of the implants at 30 and 60 days in a chronologically increasing fashion. Defect alone, AlloDerm® and Strattice™ demonstrated no such MHC signal at any time point. At 30 days, it was impossible to isolate enough RNA from our Strattice™ implants for qPCR analysis. Equally at 30 days, DCM showed no significant difference to control in terms of COX-2 expression, whereas AlloDerm® and DCD showed a significant increase from control (p≤0.05) and also expressed significantly more TNF-α than DCM (p≤0.01). At 60 days, DCM expression of COX-2 and TNF-α was significantly inferior to all other implants. There was significantly less collagen1a gene expression in DCM as compared to AlloDerm® at 30 days, and at 60 days significantly less than in Strattice™ (p≤0.05) and DCD (p≤0.01). Alpha-smooth muscle actin expression was significantly elevated in AlloDerm® at 60 days compared to DCM, and connective tissue growth factor was more highly expressed in all matrices when compared to DCM. MyoD expression was significantly higher than control in DCM at both 30 and 60 days.
CONCLUSION:
Our decellularised muscle matrix showed superiority in terms of integration, neovasculogenesis and myogenesis when compared to ADM's, both xenogeneic and native, in a muscle defect model. It also showed a trend towards less inflammation and fibrosis at both 30 and 60 days. University of Virginia, Charlottesville, VA PURPOSE: Cell culture and bioprinting have been used to simulate micro-environments that recapitulate body systems biology. However, the thickness of these constructs is limited to the diffusion gradient of nutrients required for cellular growth. The use of the body as a bioreactor to vascularize implanted three-dimensional constructs and infiltrate them with cells can provide larger constructs that could later be transposed as autologous tissue flaps. Biologic scaffolds have been used in this manner to produce larger threedimensional constructs but degrade too quickly for durable reconstructive applications. Our goal is to determine if a synthetic three-dimensional construct can be vascularized by a pedicle in vivo and incur host cellular in-growth, and potentially used as a vascularized flap for reconstructive indications.
METHODS:
Three-dimensional constructs of polycaprolactone (PCL), poly lactic-co-glycolic acid (PLGA), and polypropylene (PP) were formed into tubular cuffs (5mm in diameter, 10mm in length and 2mm wall thickness) and analyzed for porous area fraction from SEM images. The superficial epigastric pedicles were dissected and isolated bilaterally in 6 Sprague-Dawley rats, with constructs of each material individually placed around the pedicles (4 constructs for each material). At 12 weeks, the constructs were harvested, dissected free and isolated on the proximal superficial epigastric vessels. The constructs were examined grossly, then imaged with indocyanin green (ICG) fluorescence videography using the SPY Elite system to measure perfusion compared to soft tissue control. The constructs were then fixed, sectioned for histology and immunohistochemistry (IHC) to evaluate vascular in-growth and cellular invasion.
RESULTS:
Polymer cuffs were successfully produced with pore area fractions of 60.8% for PCL, 66.7% for PLGA, and 17.7% for PP. At 12 weeks, all constructs demonstrated gross evidence of surrounding tissue adherence with a uniform carpet of microvascular response. ICG perfusion at 20 seconds of PCL constructs demonstrated 101-116% of soft tissue control for roughly 2/3 of construct surface area. PLGA constructs demonstrated 109-116% of control involving 1/2 to 3/4 of the surface area of the constructs
